| 2025 | Preoperative Predictors of Subsequent Breast Cancer Events Detected on Abbreviated MRI in Patients with Early-Stage Breast Cancer
| DIAGNOSTICS |
| 2025 | Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2025 | Spatial analysis of tumor immune microenvironment of TNBC with different neoadjuvant chemotherapy outcomes using multiplex Immunofluorescence
| BREAST CANCER RESEARCH |
| 2025 | Decision-Making Patterns for Clinically Node-Positive, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: Insights From a Survey of Breast Cancer Experts | JOURNAL OF BREAST CANCER |
| 2025 | Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort | BREAST |
| 2025 | Early Postoperative Outcomes of Tumescent-Free Single-Port Robot-Assisted Nipple-Sparing Mastectomy Compared with Tumescent-Using Technique: A Substudy of Retrospective Multicenter Study (SPROUT, KoREa-BSG 14) | ANNALS OF SURGICAL ONCOLOGY |
| 2025 | APOBEC-Driven Hypermutation in the Lymphocyte-Predominant Group of Triple-Negative Breast Cancer | LABORATORY INVESTIGATION |
| 2025 | Response to "The Impact of Baseline Comorbidities and Performance Status on HER2-Targeted Therapy Outcomes" | CLINICAL BREAST CANCER |
| 2025 | Long-Term Oncologic Outcome of Breast-Conserving Treatment in Patients With Breast Cancer With BRCA Variants
| JAMA NETWORK OPEN |
| 2025 | Clinical relevance of clinical treatment score post-5 years (CTS5) in HR-positive, HER2-positive breast cancer
| NPJ BREAST CANCER |
| 2025 | Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC) | ANNALS OF ONCOLOGY |
| 2025 | Additional prognostic value of the BCT score in ER+HER2-breast cancer patients receiving a 21-gene assay-guided adjuvant treatments
| FRONTIERS IN ONCOLOGY |
| 2025 | Pathological complete response, histologic grade, and level of stromal tumor-infiltrating lymphocytes in ER + HER2- breast cancer
| BREAST CANCER RESEARCH |
| 2025 | Adjuvant Trastuzumab Plus Pertuzumab Versus Trastuzumab Alone in Patients Achieving Pathologic Complete Response After Chemotherapy With Trastuzumab and Pertuzumab: A Retrospective Cohort Study
| CLINICAL BREAST CANCER |
| 2025 | Long-term oncologic outcome of intraoperative radiotherapy (IORT) with low-energy X-rays as a tumor-bed boost in Korean patients with breast cancer
| Cancer Treatment and Research Communications |
| 2024 | Nipple-areolar complex sensory recovery based on incision placement after nipple-sparing mastectomy: a prospective nonrandomized controlled trial
| INTERNATIONAL JOURNAL OF SURGERY |
| 2024 | Capsular Contracture After Postmastectomy Radiation in Implant-Based Breast Reconstruction: Effect of Implant Pocket and Two-Stage Surgery
| JOURNAL OF BREAST CANCER |
| 2024 | Stromal tumor-infiltrating lymphocytes and pathologic response to neoadjuvant chemotherapy with the addition of platinum and pembrolizumab in TNBC: a single-center real-world study
| BREAST CANCER RESEARCH |
| 2024 | Clinical Relevance of TP53 Mutation and Its Characteristics in Breast Cancer with Long-Term Follow-Up Date
| CANCERS |
| 2024 | Age and Late Recurrence in Young Patients With ER-Positive, <i>ERBB2</i>-Negative Breast Cancer
| JAMA NETWORK OPEN |
| 2024 | Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 h+HER2-breast cancer: a retrospective analysis
| BREAST CANCER RESEARCH |
| 2024 | Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative
| NPJ BREAST CANCER |
| 2024 | Dural Metastasis in Breast Cancer: MRI-Based Morphological Subtypes and Their Clinical Implications
| CANCER RESEARCH AND TREATMENT |
| 2024 | De novo versus recurrent metastatic breast cancer affects the extent of brain metastases | JOURNAL OF NEURO-ONCOLOGY |
| 2024 | Toripalimab: a new torchlight illuminating the path for metastatic triple negative breast cancer?
| TRANSLATIONAL LUNG CANCER RESEARCH |
| 2024 | Micrometastases in axillary lymph nodes in breast cancer, post-neoadjuvant systemic therapy
| BREAST CANCER RESEARCH |
| 2024 | Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
| SCIENTIFIC REPORTS |
| 2024 | Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Human Epidermal Growth Factor 2-Positive/Triple-Negative Breast Cancer Patients With Excellent Response | JOURNAL OF BREAST CANCER |
| 2024 | Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates
| BREAST CANCER RESEARCH |
| 2024 | Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1-3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study
| BREAST CANCER RESEARCH |
| 2024 | Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer
| CANCERS |
| 2024 | Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy
| YONSEI MEDICAL JOURNAL |
| 2024 | Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial
| JOURNAL OF BREAST CANCER |
| 2024 | Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade
| CANCERS |
| 2024 | Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer-The BRAIN Study
| CANCERS |
| 2024 | Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer
| CANCERS |
| 2024 | BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer
| CELL DEATH DISCOVERY |
| 2023 | YAP1 Expression in HR+HER2- Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation
| CANCERS |
| 2023 | Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery
| SCIENTIFIC REPORTS |
| 2023 | Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review
| JOURNAL OF BREAST CANCER |
| 2023 | Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer
| JAMA NETWORK OPEN |
| 2023 | Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer
| YONSEI MEDICAL JOURNAL |
| 2023 | Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1) | BREAST CANCER |
| 2023 | Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer
| FRONTIERS IN ONCOLOGY |
| 2023 | Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1-2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy
| FRONTIERS IN ONCOLOGY |
| 2023 | Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy | RADIOLOGY |
| 2023 | Complications Including Capsular Contracture in Direct-to-Implant Breast Reconstruction With Textured Anatomical Versus Smooth Round Implants: A Single Center Retrospective Analysis
| JOURNAL OF BREAST CANCER |
| 2023 | Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physicians
| FRONTIERS IN ONCOLOGY |
| 2023 | Anaemia and pathologic complete response rate according to carboplatin dose in HER2+ breast cancer treated with neoadjuvant TCHP
| CANCER MEDICINE |
| 2022 | Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy
| JOURNAL OF BREAST CANCER |
http://orcid.org/0000-0002-8778-9686
(36336893800)
